09/25/2015 // JusticeNewsFlash // (press release)
Canada – A class-action lawsuit is being pursued over the diabetes drug Avandia. As reported by CBCNews.ca, lawyers in Nova Scotia have requested that a class action be certified against GlaxoSmithKline, alleging that their diabetes drug is defective.
